N-able, Inc.
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
9. Earnings Per Share
- Earnings Per Share
Basic and Diluted Earnings Per Share
A reconciliation of the number of shares in the calculation of basic and diluted earnings per share follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| (in thousands) | ||||
| Basic earnings per share: | ||||
| Numerator: | ||||
| Net income (loss) | $1,383 | $10,757 | $(9,801) | $27,668 |
| Denominator: | ||||
| Weighted-average common shares outstanding used in computing basic earnings per share | 187,599 | 185,506 | 188,213 | 184,840 |
| Basic earnings per share | $0.01 | $0.06 | $(0.05) | $0.15 |
| Diluted earnings per share: | ||||
| Numerator: | ||||
| Net income (loss) | $1,383 | $10,757 | $(9,801) | $27,668 |
| Denominator: | ||||
| Weighted-average shares used in computing basic earnings per share | 187,599 | 185,506 | 188,213 | 184,840 |
| Add dilutive impact of employee equity plans | 821 | 2,568 | — | 3,199 |
| Weighted-average shares used in computing diluted earnings per share | 188,420 | 188,074 | 188,213 | 188,039 |
| Diluted earnings per share | $0.01 | $0.06 | $(0.05) | $0.15 |
The dilutive impact of employee equity awards was not applicable to the calculation of diluted net loss per share for the nine months ended September 30, 2025, as the effect would have been anti-dilutive.
The following weighted-average outstanding shares of common stock equivalents were excluded from the computation of the diluted net income per share attributable to common stockholders for the three months ended September 30, 2025 and the three and nine months ended September 30, 2024, because their effect would have been anti-dilutive or for which the performance condition had not been met at the end of the period:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | |
| (in thousands) | ||||
| Restricted stock units | 8,055 | 5 | — | 2 |
| Total anti-dilutive shares | 8,055 | 5 | — | 2 |
Share Repurchase Program
On March 11, 2025, our board of directors approved a share repurchase program (the “Repurchase Program”) authorizing the repurchase of up to $75.0 million of our common stock, par value $0.001 per share (the “Common Stock”). The timing and total amount of stock repurchases will depend upon business, economic, and market conditions, corporate and regulatory requirements, prevailing stock prices, and other considerations. The Repurchase Program has no expiration date, may be suspended or discontinued at any time without notice, and does not obligate the Company to acquire any specific dollar amount or numbers of shares of Common Stock. Under the Repurchase Program, we repurchased 1,237,001 shares for $10.0 million and 2,487,179 shares for $20.0 million during the three and nine months ended September 30, 2025, respectively. As of September 30, 2025, we are authorized to repurchase a remaining $55.0 million of our common stock under the Repurchase Program. See Part II - Item 2. Unregistered Sales of Equity and Use of Proceedsfor additional information on the Repurchase Program.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.